Endocrine Disrupting Chemicals (EDCs)

EDCs can cause serious and irreversible effects on human health and the environment, even at very low doses. Proper identification and risk management are crucial for regulatory compliance and safety.

Definition and Identification

Criteria Description Examples
WHO/IPCS Definition Alters function of endocrine system causing adverse effects BPA, Phthalates, PCBs
EU Criteria Shows endocrine mode of action with adverse effects DEHP, DBP, BBP
Suspected EDCs Some evidence of endocrine disruption Various pesticides, plasticizers

Regulatory Framework

REACH Regulation

  • Identification as SVHC
  • Authorization requirement
  • Restriction provisions
  • Information requirements

Biocidal Products Regulation

  • Specific EDC criteria
  • Cut-off criteria application
  • Risk assessment requirements

Plant Protection Products

  • EDC-specific provisions
  • Approval criteria
  • Safety assessments

Testing and Assessment

Level Test Methods Endpoints
In vitro Receptor binding, Cell proliferation Mechanistic information
In vivo screening Uterotrophic, Hershberger assays Endocrine activity
Definitive tests Extended one-generation studies Adverse effects

Common EDCs and Sources

Industrial Chemicals

  • Bisphenol A (BPA)
  • Phthalates
  • Alkylphenols
  • PCBs

Pesticides

  • DDT and metabolites
  • Chlorpyrifos
  • Atrazine
  • Vinclozolin

Consumer Products

  • Personal care products
  • Food contact materials
  • Textiles and clothing
  • Electronics

Risk Management Measures

Regulatory Actions

  • Substance restrictions
  • Use limitations
  • Substitution requirements
  • Monitoring programs

Industry Measures

  • Alternative assessment
  • Safe substitution
  • Exposure controls
  • Supply chain communication

Important Considerations:

Critical Safety Information: